Mary Collins | |
---|---|
Born | Mary Katharine Levinge Collins |
Nationality | British |
Fields | Immunology |
Institutions | |
Alma mater |
|
Thesis | The mechanism of action of mitogens for cultured murine fibroblasts : regulation of mitogenic receptors and response (1983) |
Academic advisors | Enrique Rozengurt |
Known for | Development of lentivirus viral vectors |
Notable awards | FMedSci |
Spouse | Tim Hunt (m. 1995) |
Children | Two daughters, born c. 1996 and 2000 |
Website iris |
Mary Katharine Levinge Collins is a British Professor of Immunology. She is Dean of Research at the Okinawa Institute of Science and Technology in Japan. Formerly, Collins taught in the Division of Infection and Immunity at University College London, and was the head of the Division of Advanced Therapies at the National Institute for Biological Standards and Control, and the Director of the Medical Research Council Centre for Medical Molecular Virology. Her research group studies the use of viruses as vectors for introducing new genes into cells, which can be useful for experimental cell biology, for clinical applications such as gene therapy, and as cancer vaccines.
Collins was educated at the University of Cambridge, where she studied Natural Sciences (Biochemistry). She did her postgraduate research work supervised by Enrique Rozengurt at the Imperial Cancer Research Fund for which she was awarded a PhD by the University of London in 1983.
After her PhD, she moved to a postdoctoral fellowship with Avrion Mitchison at University College London studying the locations of T cell receptor gene clusters, and next worked with Richard C. Mulligan at the Whitehead Institute at the Massachusetts Institute of Technology, where she developed retroviral vectors expressing cytokines and cytokine receptors.